Ptc Therapeutics (PTCT) Other Working Capital Changes (2012 - 2026)

Ptc Therapeutics' Other Working Capital Changes history runs 14 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 121.14% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$12.7 million, a 198.47% decrease from a year earlier, with the FY2025 full-year figure at -$4.0 million, down 181.31% from the prior year.
• Other Working Capital Changes fell to -$1.5 million in Q1 2026 per PTCT's latest filing, from $300000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $104.5 million in Q4 2023 and bottomed at -$93.9 million in Q1 2024.
• The 5-year median for Other Working Capital Changes is $1.7 million (2025), against an average of $2.0 million.
• Across the five-year window, Other Working Capital Changes soared 1451.77% in 2024 and sank 121.14% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$423000.0 in 2023, then surged by 1451.77% to $5.7 million in 2024, then tumbled by 94.75% to $300000.0 in 2025, then plunged by 607.33% to -$1.5 million in 2026.
• Per Business Quant, the three latest PTCT Other Working Capital Changes figures stand at -$1.5 million (Q1 2026), $300000.0 (Q4 2025), and -$8.1 million (Q3 2025).